These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9024136)

  • 1. Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury.
    Oskarsson HJ; Heistad DD
    Circulation; 1997 Feb; 95(3):557-9. PubMed ID: 9024136
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease and hypertension.
    Oliver JA
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):299-306. PubMed ID: 7922190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension.
    Wu R; Duchemin S; Laplante MA; De Champlain J; Girouard H
    Am J Hypertens; 2011 Nov; 24(11):1239-44. PubMed ID: 21833043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II and the pathophysiology of cardiovascular remodeling.
    Williams B
    Am J Cardiol; 2001 Apr; 87(8A):10C-17C. PubMed ID: 11334763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease.
    Püntmann VO; Hussain MB; Mayr M; Xu Q; Singer DR
    Vascul Pharmacol; 2005 Oct; 43(4):277-82. PubMed ID: 16243586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular remodeling and its correction: toward a comprehensive strategy.
    Bühler FR; Laragh JH; Holzgreve H
    Am J Med; 1993 Apr; 94(4A):1S-3S. PubMed ID: 8488850
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin and the Heart. Symposium proceedings. Hamburg, October 22-24, 1992.
    Basic Res Cardiol; 1993; 88 Suppl 1():1-222. PubMed ID: 8102846
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats.
    Wassmann S; Bäumer AT; Strehlow K; van Eickels M; Grohé C; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2001 Jan; 103(3):435-41. PubMed ID: 11157697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.
    Brunner HR
    Am J Cardiol; 2001 Apr; 87(8A):3C-9C. PubMed ID: 11334762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiology patient page. What is an angiotensin converting enzyme inhibitor?
    Sweitzer NK
    Circulation; 2003 Jul; 108(3):e16-8. PubMed ID: 12876137
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research.
    Ferrario CM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):3-14. PubMed ID: 17083068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis.
    Ocaranza MP; Moya J; Barrientos V; Alzamora R; Hevia D; Morales C; Pinto M; Escudero N; García L; Novoa U; Ayala P; Díaz-Araya G; Godoy I; Chiong M; Lavandero S; Jalil JE; Michea L
    J Hypertens; 2014 Apr; 32(4):771-83. PubMed ID: 24463937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of angiotensin II on cerebral blood flow autoregulation in health and disease.
    Squire IB
    J Hypertens; 1994 Nov; 12(11):1203-8. PubMed ID: 7868866
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis].
    Okura T; Higaki J
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():161-6. PubMed ID: 15813062
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidative stress-associated hypertension in surgically induced brain injury patients: effects of β-blocker and angiotensin-converting enzyme inhibitor.
    Velayutham PK; Adhikary SD; Babu SK; Vedantam R; Korula G; Ramachandran A
    J Surg Res; 2013 Jan; 179(1):125-31. PubMed ID: 23020955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress may explain how hypertension is maintained by normal levels of angiotensin II.
    Romero JC; Reckelhoff JF
    Braz J Med Biol Res; 2000 Jun; 33(6):653-60. PubMed ID: 10829093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.
    Touyz RM
    Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.